PT-141 (Bremelanotide)
A melanocortin agonist that increases sexual desire by acting on the central nervous system rather than on blood flow.
FDA-approved·Regulatory status as of May 2026
Relevance for women
FDA-approved (as Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women — the strongest evidence-based peptide option in this category.
Articles on PT-141 (Bremelanotide)
How Much Does Peptide Therapy Cost?
A realistic breakdown of what peptide therapy costs — consults, the peptides themselves, bloodwork, and why insurance generally won't cover it.
PT-141 (Bremelanotide) for Women: Libido, Safety, and What to Know
PT-141 / Vyleesi is FDA-approved for low sexual desire in premenopausal women. Here's how it works, what the research shows, and what to know about safety.
What Are Peptides? A Woman's Guide to Hormone & Wellness Peptides
A clear, evidence-based guide to peptides for women — what they are, which ones have real research behind them, and what to know before considering peptide therapy.
Providers that offer PT-141 (Bremelanotide)
- 4.6/5
Solace MD
Higher price band, faster shipping, more personal care — the right fit if cost isn't the primary constraint.
- 4.5/5
Evergreen Women's Health
Strongest fit for perimenopausal women seeking continuity of care — pairs hormone testing with peptide protocols.
- 4.0/5
Canopy Telehealth Clinic
Broad catalog and broad geographic reach; longer intake process but thorough lab work.
See the full provider comparison for all peptides side by side.